GERD IP, A Subsidiary of Medigus, Files Complaint with Delaware District Court Alleging Infringement of two Proprietary Patents

OMER, Israel, July 13, 2020 - Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that GERD IP, Inc., a Delaware corporation and majority owned subsidiary of Medigus, filed a complaint with the United States District Court for the District of Delaware, alleging infringement of two of GERD IP’s proprietary patents. The infringement complaint was brought against an active company in the field of medical devices.

The claim for patent infringement refers to two patents issued by the United States Patent and Trademark Office, owned by GERD IP, Inc. In its complaint, GERD IP requested a trial by jury based on the assertion that the defendant has and continues to directly infringe the company's patents by making, using, testing, selling, offering for sale or importing into the United States products and services covered by GERD IP’s patents.

The technology underlying the allegedly infringed patents serves as the foundation of a device used to perform a minimally invasive, trans-oral fundoplication surgical procedure for the treatment of patients suffering from Gastroesophageal Reflux Disease.